A randomized, double-blind, placebo-controlled, dose escalation phase 1 clinical trial was conducted to assess the safety and tolerability of FAHF-2 in food allergy patients (2.2 g, 3.3 g, or 6.6 g, 3 times a day for 7 days)
But here's the catch: you're locked into that commitment even if you stop taking medication
Despite initially promising results, SAR425899 has been discontinued after phase 2 trials showed treatment related gastrointestinal disorders (NCT03437720)
It should slide gently toward the powder at the bottom
If a year of GLP-1 treatment prevents a cardiovascular event, a diabetes diagnosis, or a joint replacement surgery, the cost-benefit equation looks very different
Medicines that may change insulin needs include corticosteroids, certain antipsychotics, thyroid hormones, diuretics, ACE inhibitors, ARBs, some antibiotics, sulfonylureas, GLP-1 receptor agonists, and thiazolidinediones